Illumina to acquire NextBio

Illumina (ILMN -0.7%) is set to acquire NextBio, which has the capability to "aggregate and analyze large quantities of phenotypic and genomic data for research and clinical applications."

ILMN says the deal will allow it to "offer customers enterprise level bioinformatics solutions that accelerate the discovery of new associations between the human genome and disease, and ultimately, enable the application of those discoveries within healthcare." (PR)

ILMN also affirms its 2013 guidance for good measure.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs